MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPMENT PLAN

File: 110596_sep96_decls4_0001.txt
Page: 0001
Total Pages: 2

Subject: MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPMENT PLAN        

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPMENT PLAN                                        

Document Number:          1

Folder SEQ  #:         64









                               OFFICE OF THE SECRETARY OF DEFENSE


                                     WASHINGTON. D.C. Z0301




              MEMORANDUM FOR ARMED SERVICES BIOMEDICAL RESEARCH EVALUATION AND
                             MANAGEMENT (ASBREM) COMMITTEE ATTN: CHAIRPERSON,
                             JOINT TECHNOLOGY COORDINATING GROUP (JTCG)-4

              SUBJECT: Medical Biological Defense Research and Development
                        Plan



                  We request that you develop a comprehensive Medical
              Biological Defense Research and Development Plan. The principal
              thrust of your planning efforts should be focused on development
              of more efficacious vaccines and other medical countermeasures
              against high-priority threat agents. Your plan should address, at
              a minimum, the following key areas:

                        o Mission statement, program goals, and intermediate
              planning objectives for near, mid, and far-term threats.

                        o Administrative overview which identifies program
              organization, programmatic requirements identified by Services
              and the Joint Staff, and intramural and extramural participants
              in the research and development effort.

                        o Science and Technology overview which discusses
              validated threat agents identified by the Defense Intelligence
              Agency and Armed Forces Medical Intelligence Center, and
              describes how the existing science and technology program
              addresses these agents.

                        o Advanced Development/DeTftonstration and Validation
              overview which discusses the status of product development to
              address biological threats, and highlights transition decisions,
              milestones, and anticipated product availability.

 and
              outyear funding projections for each program element and project
              (6.1 - 6.4) which supports the medical biological defense
              program; in addition, a matrix should be provided which indicates
              how these funds are applied toward specific threat agents.

                        o Analysis and critique of current investment strategy
              which addresses adequacy of support for developing'
              countermeasures to high-priority threats, and discusses current
              and anticipated opportunities to leverage partnerships with
              industry, academia and other government agencies.

                        o Discussion of management challenges to include
              adequacy of current DoD infrastructure (facilities and personnel)
              to support the medical biological defense program; and inter-
              Departmental interactions with the Food and Drug Administration.

Document 2 f:/Week-36/BX003203/MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPMENT PLAN/medical biological defense research and developm:1104960910075
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPMENT PLAN
Folder Seq # = 64
Subject = MEDICAL BIOLOGICAL DEFENSE RESEARCH AND DEVELOPM
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996